CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-17 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Purchase | +5,000 | $27.65 | $138K | 5,000 |
| 2022-02-15 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,184 | $40.25 | $48K | 14,950 |
| 2022-02-15 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,167 | $40.25 | $47K | 11,740 |
| 2021-12-20 | Thoma Jeanne Director | Purchase | +1,072 | $46.47 | $50K | 17,785 |
| 2021-12-07 | Pera Antonio R Director | Purchase | +3,000 | $42.26 | $127K | 19,713 |
| 2021-12-06 | HAUGHEY THOMAS Director | Purchase | +2,500 | $39.38 | $98K | 30,202 |
| 2021-11-19 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Grant or award | +13,460 | 13,460 | ||
| 2021-11-19 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Grant or award | +1,332,620 | 1,332,620 | ||
| 2021-11-19 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +383,226 | 383,226 | ||
| 2021-09-08 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −2,577 | $28.20 | $73K | 162,426 |
| 2021-04-12 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −1,878 | $31.86 | $60K | 114,321 |
| 2021-04-12 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Shares withheld for taxes | −3,042 | $31.86 | $97K | 112,500 |
| 2021-04-06 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −337 | $33.69 | $11K | 116,199 |
| 2021-04-06 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Shares withheld for taxes | −612 | $33.69 | $21K | 115,542 |
| 2021-03-31 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −278 | $36.14 | $10K | 116,536 |
| 2021-03-31 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Shares withheld for taxes | −508 | $36.14 | $18K | 116,154 |
| 2021-03-29 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −524 | $32.68 | $17K | 116,814 |
| 2021-03-29 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Shares withheld for taxes | −953 | $32.68 | $31K | 116,662 |
| 2021-03-29 | Schrepfer Robert W SVP - NEW BUS DEV & SPEC SALES | Shares withheld for taxes | −5,566 | $32.68 | $182K | 87,477 |
| 2021-03-23 | Marken James G. SVP OPS & PROD DEV | Grant or award | +32,041 | 117,338 |
Page 24 of 31 · 601 trades